Streptococcus Pneumoniae Infection - Pipeline Review, H1 2015

RnRMarketResearch.com adds ‘Streptococcus Pneumoniae Infection - Pipeline Review, H1 2015’ to its store. This report provides an overview of the Streptococcus Pneumoniae Infection's therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Streptococcus Pneumoniae Infection, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Streptococcus Pneumoniae Infection and special features on late-stage and discontinued projects.

Purchase a copy of this report at http://www.rnrmarketresearch.com/contacts/purchase?rname=400809 . (This is a premium report price at US$2000 for a single user PDF license)

Scope:

• The report provides a snapshot of the global therapeutic landscape of Streptococcus Pneumoniae Infection

• The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities

• The report reviews key players involved in the therapeutics development for Streptococcus Pneumoniae Infection and enlists all their major and minor projects

• A review of the Streptococcus Pneumoniae Infection products under development by companies and universities/research institutes based on information derived from company and industry-specific sources

• Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages

Inquire for discount of this report at http://www.rnrmarketresearch.com/contacts/discount?rname=400809 . (This is a premium report price at US$2000 for a single user PDF license)

Reasons to buy:

• Provides strategically significant competitor information, analysis, and insights...